Mark Lackner

SVP, Head of Biology, Ideaya Biosciences (United States).

Companies

Zentalis Pharmaceuticals, Inc.Chief Scientific Officer Jan 3, 2024 to Feb 5, 2025¹
Ideaya Biosciences (United States)SVP, Head of Biology May 22, 2019 to Feb 26, 2021²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZentalis Pharmaceuticals, Inc., Chief Scientific Officer
2
SEC EDGARIdeaya Biosciences (United States), SVP, Head of Biology